Yoon Jeon

The First Total Synthesis of (±)-Ingenol

Jeffrey D. Winkler, Meagan B. Rouse, Michael F. Greaney et al. · Journal of the American Chemical Society · 2002 · 165 citations

Design and Synthesis of <i>N</i>-[(4-Methoxyphenoxy)carbonyl]-<i>N</i>-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with Efficacious Glucose and Lipid-Lowering Activities

Pratik Devasthale, Sean Chen, Yoon Jeon et al. · Journal of Medicinal Chemistry · 2004 · 108 citations · Full text

Muraglitazar, a Novel Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves β-Cell Function in <i>db/db</i> Mice

Thomas Harrity, Dennis Farrelly, Aaron Tieman et al. · Diabetes · 2006 · 80 citations · Full text

Ppar Target Genes, Immunology, Pharmacotherapy +19

Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species

Wu Yang, Yufeng Wang, Amy Lai et al. · Journal of Medicinal Chemistry · 2020 · 21 citations · Full text

Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent

Yoon Jeon, Wu Yang, Jennifer X. Qiao et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 19 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Antimicrobial Drug Discovery +12